Summary
The product Methandienone, manufactured by DuncanPharma.eu, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number JF6108, was submitted by the reseller DuncanPharma.eu and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Methandienone, with a concentration of 12.10 mg.
The testing process was conducted on 24 May 2024. While the results confirm the presence of the active ingredient, scrutiny of reseller-submitted samples is essential to ensure reliability. Resellers may select specific batches that meet high-quality standards, raising questions about product consistency across the broader market. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: DuncanPharma.eu
- Product Name: Methandienone
- Active Ingredient: Methandienone
- Batch Number: JF6108
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #42629
- Testing Ordered: 15 May 2024
- Sample Received: 23 May 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Optitropin.EU (Reseller)
- Analysis Paid For By: Optitropin.EU
Testing Results
- Specification: 10.00 mg/ml
- Measured Concentration: 12.10 mg
- Accuracy: 121.00%
- Variance: 21.00%
Verification Details
Verification URL: https://janoshik.com/tests/42629_AYEURUV8TEAS
Evaluation of Reseller-Submitted Testing
This analysis highlights the presence of Methandienone in the tested product but warrants careful evaluation due to its submission and funding by the reseller DuncanPharma.eu. Resellers often select optimal batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms the presence of Methandienone in the tested sample, with a measured concentration of 12.10 mg. This result reflects the quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
